Jianrong Zhou

Jianrong Zhou

Auto-generated profile, based on publicly available information

Jianrong Zhou

Paediatric Cardiac Surgery Centre, National Clinical Research Centre for Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College/National Centre for Cardiovascular Diseases, China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 July 2023 in Experimental and Therapeutic Medicine
Verified
Journal Article
Open access
PDF file
XHXi Huang
Xi Huang
QJQi Ji
Qi Ji
CSChen-Yi She
Chen-Yi She
YCYi Cheng
Yi Cheng
JZJian-Rong Zhou
Jian-Rong Zhou
QWQingming Wu
Qingming Wu
Lipid metabolic disorders, oxidative stress and inflammation in the liver are key steps in the progression of non‑alcoholic fatty liver disease (NAFLD). Ophiopogonin D (OP‑D), the main active ingredient of Ophiopogon japonicus, exhibits several pharmacological activities such as antioxidant and anti‑inflammatory activities. Therefore, the current study aimed to explore the role of OP‑D in NAFLD in a high‑fat diet (HFD)‑induced obesity mouse model. To investigate the effect of OP‑D on NAFLD in vivo, a NAFLD mouse model was established following feeding mice with HFD, then the mice were randomly treated with HFD or HFD + OP‑D for 4 weeks. Subsequently, primary mouse hepatocytes were isolated, and enzyme‑linked immunosorbent assay, reverse transcription‑quantitative PCR western blotting and immunofluorescence analysis were used for assessment to explore the direct effect of OP‑D in vitro. The results of the present study indicated that OP‑D could ameliorate NAFLD in HFD‑induced obese mice by regulating lipid metabolism and antioxidant and anti‑inflammatory responses. Additionally, OP‑D treatment decreased lipogenesis and inflammation levels in vitro, suggesting that the NF‑κB signaling pathway may be involved in the beneficial effects of OP‑D on NAFLD.

14 February 2022 in Cardiology Research and Practice
Verified
Journal Article
Open access
PDF file
XLXiang Liu
Xiang Liu
JTJiazichao Tu
Jiazichao Tu
ZZZiqin Zhou
Ziqin Zhou
BHBingxin Huang
Bingxin Huang
JZJianrong Zhou
Jianrong Zhou
JCJimei Chen
Jimei Chen
Background. Trimethylamine-N-oxide (TMAO) has been shown to be an important player in cardiovascular disease (CVD) by promoting vascular inflammation and endothelial dysfunction. We recently found that exosomes (Exos) released from TMAO-activated hepatocytes (TMAO-Exos) could significantly induce inflammation and endothelial dysfunction. However, understandings of how are the Exos secreted by hepatocytes, where are they distributed in vivo, and what effects will they have on vascular inflammation remain limited. The present study aimed to explore the hub genes involved in the production of TMAO-Exos and their distributions in vivo and effects on inflammation. Methods. The transcriptome profiles of primary rat hepatocytes stimulated with TMAO were obtained from the GSE135856 dataset in the Gene Expression Omnibus repository, and the hub genes associated with Exos were screened and verified by qPCR. Next, Exos derived from TMAO-treated hepatocytes were isolated using differential centrifugation and given intravenously to mice. After 24h, the distributions of DiI-labelled Exos were visualized with a fluorescence microscope, and the levels of proinflammatory genes in the aorta were detected by qPCR. Results. Phgdh, Mdh2, Echs1, Rap2a, Gpd1l, and Slc3a2 were identified as hub genes that may be involved in the production of TMAO-Exos. And TMAO-Exos were found to be efficiently taken up by cardiomyocytes, hepatocytes, and endothelial cells in the aorta and gastrocnemius muscle. Furthermore, TMAO-Exos, but not control-Exos, could significantly promote the mRNA expressions of Tnf, Icam1, Sele, and Cox-2 in the aorta. Conclusions. We provided clues about how TMAO may stimulate hepatocytes to produce Exos and further offered evidence that Exos secreted by TMAO-treated hepatocytes could be widely distributed in vivo and promote vascular inflammation.

4 September 2026 in Frontiers in Cardiovascular Medicine
Verified
Journal Article
Open access
PDF file
GLGuanqing Li
Guanqing Li
ACAijun Chen
Aijun Chen
TYTing Yan
Ting Yan
HCHaisheng Chen
Haisheng Chen
BLBin Li
Bin Li
XZXiong Zhang
Xiong Zhang
Objective: To evaluate long-term outcomes of hybrid aortic arch repair for aortic arch lesions and identify factors associated with late mortality. Methods: We retrospectively enrolled 103 patients with aortic arch lesions who received hybrid aortic arch repair at our center between January 2010 and September 2025. General clinical data, lesion types, surgical methods, perioperative outcomes, and long-term follow-up data were collected. Based on the bypass strategy, patients were divided into an ascending aorta (AA) inflow group ( n = 48) and a cervical debranching group ( n = 55). Kaplan–Meier analysis and Cox proportional hazards regression were used to evaluate long-term outcomes and identify factors associated with late mortality. Results: The mean age was 72.0 ± 10.2 years, and 83.5% were men. Diagnoses included intramural hematoma (40.8%), type B dissection (17.5%), type A dissection (14.6%), arch aneurysm (14.6%), and penetrating ulcer (12.6%). All patients successfully completed the procedure, with no intraoperative or 30-day deaths. During a median follow-up of 75.8 months (IQR, 29–128), procedure-related stroke occurred in 8 patients (7.8%), renal dysfunction in 18 (17.5%), and spinal cord ischemia in none. Eleven patients (10.7%) died, and 8 (7.8%) underwent reintervention, mainly for retrograde type A dissection, endoleak, or new-entry dilation. Survival at 1, 3, 5, and 10 years was 98.0%, 94.6%, 89.0%, and 85.8%; freedom from reintervention was 97.9%, 94.2%, 91.5%, and 89.9%. Cervical debranching was associated with better survival than ascending aortic inflow (log-rank P = 0.024), with similar freedom from reintervention (log-rank P = 0.88). In an exploratory multivariable Cox model, older age, ascending aorta inflow, and preoperative renal dysfunction were associated with late mortality. Conclusions: Hybrid aortic arch repair was associated with favorable long-term survival, durable freedom from reintervention, and acceptable neurological outcomes in this single-center cohort. The observed survival advantage in the cervical debranching group should be interpreted cautiously, as ascending aorta inflow was preferentially used in patients with more complex proximal aortic disease. These findings should be considered hypothesis-generating and require validation in larger multicenter studies.

16 February 2021 in Research Square
Verified
Preprint
Open access
PDF file
JZJianrong Zhou
Jianrong Zhou
YZYing Zheng
Ying Zheng
GLGuiying Liang
Guiying Liang
XQXianyu Qin
Xianyu Qin
HYHang Yang
Hang Yang
JCJimei Chen
Jimei Chen
Background The Williams-Beuren syndrome (WBS) is a multiple phylogenetic disorder, caused by the hemizygous deletion of 1.55 to 1.84 Mb on chromosome 7q11.23, which encodes a fragment of 26 to 28 genes. Among these genes, the deletion of the elastin (ELN) gene haplotype is the main cause of cardiovascular abnormalities. Other genes, such as CLIP2, GTF2IRD1, and GTF2I, may be associated with specific cognitive and craniofacial features. However, genes associated with specific neurocognitive phenotypes are still controversially discussed. The purpose of this study is to further explore the mechanism of neurodevelopmental disorders in patients with Williams-Beuren syndrome.Patients and methods Patients who had been diagnosed with WBS were recruited. The deletion was precisely defined by chromosome microarray analysis and the clinical phenotype was evaluated. Results This study identified nine patients with atypical deletions from 111 patients with WBS. One patient had normal neurodevelopmental with deletion of Williams-Beuren syndrome chromosomal region (WBSCR) telomere side genes, including GTF2I and GTF2IRD1, while another patient retained these genes but showed neurodevelopmental abnormalities. Seven of the eight patients with the WBSCR22 gene deletion developed growth restriction.Conclusions By comparing the genotype and phenotype of patients with typical deletions and atypical deletions, the deletion of GTF2I and GTF2IRD1 genes alone insufficient to induce typical neurocognitive phenotypes in WBS patients. The BAZ1B, FZD9, and STX1A genes may play an important role in the neurodevelopment of patients with WBS. Furthermore, the deletion of the WBSCR22 gene may be the main cause of physical growth restriction in WBS patients.